Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
BACKGROUND
Coinfection with human immunodeficiency virus (HIV) has been shown to influence the natural history of hepatitis C infection.


OBJECTIVE
Our interest was to determine if HIV coinfection influences the prevalence of cryoglobulinemia in hepatitis C virus (HCV) infected persons.


METHODS
A total of 384 HCV RNA positive (234 HIV-infected and 150 HIV-uninfected) participants were tested at two visits, 18 months apart, for HCV and HIV RNA, CD4, and liver enzyme levels. Serum cryoglobulin levels were measured at a subsequent visit for a subset of the sample.


RESULTS
HIV-infected participants had significantly higher HCV RNA levels (P < 0.0001) and aspartate transaminase (AST) levels (P < 0.0001), but not alanine transaminase (ALT) levels (P > 0.05) as compared with HIV-uninfected participants. These findings were consistent at both visits and no significant changes were observed between visits. Fifty (19%) of the 264 participants tested had detectable cryoglobulins. No difference was observed in HIV seropositivity among participants with or without cryoglobulinemia (68% versus 61%; odds ratio = 1.34, P = 0.37). However, among HIV coinfected participants, elevated AST levels (P = 0.04) and lower CD4 levels (P = 0.02) were associated with cryoglobulinemia.


CONCLUSIONS
While previously reported associations were found between HIV and coinfection with HCV in this study, we did not find an association between HIV infection and cryoglobulinemia.
Centers for Disease Control and Prevention, Mailstop G19, 1600 Clifton Road, NE, Atlanta, GA 30333, USA. cdezzutti@cdc.gov
Charlene S
CS
Dezzutti
Jacquie
J
Astemborski
David L
DL
Thomas
James H
JH
Marshall
Thania
T
Cabrera
Michael
M
Purdy
David
D
Vlahov
Richard S
RS
Garfein
D000328:Adult; D003449:Cryoglobulinemia / Q000150:complications / Q000453:epidemiology* / Q000821:virology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000821:virology; D015497:HIV-1; D016174:Hepacivirus; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology / Q000821:virology; D006801:Humans; D008297:Male; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
D012367:RNA, Viral